참고문헌
- Abed E, Moreau R (2007). Importance of melastatin-like transient receptor potential 7 and cations (magnesium, calcium) in human osteoblast-like cell proliferation. Cell Prolif, 40, 849-65. https://doi.org/10.1111/j.1365-2184.2007.00476.x
- Allen JE, El-Deiry WS (2012). Regulation of the human TRAIL gene. Cancer Biol Ther, 13, 1143-51. https://doi.org/10.4161/cbt.21354
- Bodding M (2007). TRP proteins and cancer. Cell Signal, 19, 617-24. https://doi.org/10.1016/j.cellsig.2006.08.012
- Bucur O, Ray S, Bucur MC, et al (2006). APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Front Biosci, 11, 1549-68. https://doi.org/10.2741/1903
- Fang L, Zhan S, Huang C, et al (2013). TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharmacol, 272, 713-25. https://doi.org/10.1016/j.taap.2013.08.009
- Gaudet R (2008). A primer on ankyrin repeat function in TRP channels and beyond. Mol Biosyst, 4, 372-9. https://doi.org/10.1039/b801481g
- Guilbert A, Gautier M, Dhennin-Duthille I, et al (2013). Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur J Cancer, 49, 3694-707. https://doi.org/10.1016/j.ejca.2013.07.008
- Holoch PA, Griffith TS (2009). TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur J Pharmacol, 625, 63-72. https://doi.org/10.1016/j.ejphar.2009.06.066
- Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
-
Jin J, Desai BN, Navarro B, et al (2008). Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering
$Mg^{2+}$ homeostasis. Science, 322, 756-60. https://doi.org/10.1126/science.1163493 - Koschny R, Walczak H, Ganten TM (2007). The promise of TRAIL--potential and risks of a novel anticancer therapy. J Mol Med (Berl), 85, 923-35. https://doi.org/10.1007/s00109-007-0194-1
- Kunzelmann K (2005). Ion channels and cancer. J Membr Biol, 205, 159-73. https://doi.org/10.1007/s00232-005-0781-4
- Latorre R, Zaelzer C, Brauchi S (2009). Structure-functional intimacies of transient receptor potential channels. Q Rev Biophys, 42, 201-46. https://doi.org/10.1017/S0033583509990072
- Lehen'kyi V, Shapovalov G, Skryma R, et al (2011). Ion channnels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. Am J Physiol Cell Physiol, 301, 1281-9.
- Lescarbeau RM, Kaplan DL (2014). Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling. BMC Cancer, 14, 325. https://doi.org/10.1186/1471-2407-14-325
- Minke B, Cook B (2002). TRP channel proteins and signal transduction. Physiol Rev, 82, 429-72. https://doi.org/10.1152/physrev.00001.2002
- Montell C (2005). The TRP superfamily of cation channels. Sci STKE, 2005, 3.
- Montell C, Birnbaumer L, Flockerzi V (2002). The TRP channels, a remarkably functional family. Cell, 108, 595-8. https://doi.org/10.1016/S0092-8674(02)00670-0
- Munshi A, Pappas G, Honda T, et al (2001). TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene, 20, 3757-65. https://doi.org/10.1038/sj.onc.1204504
- Nieminen AI, Partanen JI, Hau A, et al (2007). c-Myc primed mitochondria determine cellular sensitivity to TRAILinduced apoptosis. EMBO J, 26, 1055-67. https://doi.org/10.1038/sj.emboj.7601551
- Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, et al (2012). [TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters]. Bull Cancer, 99, 655-64.
- Runnels LW, Yue L, Clapham DE (2001). TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science, 291, 1043-7. https://doi.org/10.1126/science.1058519
- Ryazanova LV, Rondon LJ, Zierler S, et al (2010). TRPM7 is essential for Mg(2+) homeostasis in mammals. Nat Commun, 1, 109. https://doi.org/10.1038/ncomms1108
- Sahni J, Scharenberg AM (2008). TRPM7 ion channels are required for sustained phosphoinositide 3-kinase signaling in lymphocytes. Cell Metab, 8, 84-93. https://doi.org/10.1016/j.cmet.2008.06.002
- Saraswati S, Kumar S, Alhaider AA (2013). alpha-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway. Mol Cancer, 12, 147. https://doi.org/10.1186/1476-4598-12-147
- Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Stuckey DW, Shah K (2013). TRAIL on trial: preclinical advances in cancer therapy. Trends Mol Med, 19, 685-94. https://doi.org/10.1016/j.molmed.2013.08.007
- Tannock IF, de Wit R, Berry WR, et al (2004). Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med, 351, 1502-12. https://doi.org/10.1056/NEJMoa040720
- Van Haute C, De Ridder D, Nilius B (2010). TRP channels in human prostate. ScientificWorldJournal, 10, 1597-611. https://doi.org/10.1100/tsw.2010.149
- Wang D, Lu J, Tindall DJ (2013). Androgens regulate TRAILinduced cell death in prostate cancer cells via multiple mechanisms. Cancer Lett, 335, 136-44. https://doi.org/10.1016/j.canlet.2013.02.001
- Wiley SR, Schooley K, Smolak PJ, et al (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-82. https://doi.org/10.1016/1074-7613(95)90057-8
- Yu M, Huang C, Huang Y, et al (2013). Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts. Inflamm Res, 62, 961-70. https://doi.org/10.1007/s00011-013-0653-9
피인용 문헌
- Role of TRP ion channels in cancer and tumorigenesis vol.38, pp.3, 2016, https://doi.org/10.1007/s00281-015-0525-1
- New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements vol.74, pp.1, 2016, https://doi.org/10.1007/s12013-015-0712-7
- TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth vol.38, pp.4, 2017, https://doi.org/10.3892/or.2017.5883
- TRPM7 in CHBP-induced renoprotection upon ischemia reperfusion-related injury vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-22852-2
- Ion channels as therapeutic antibody targets vol.11, pp.2, 2019, https://doi.org/10.1080/19420862.2018.1548232